Raphael Pharmaceutical Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
RAPHStored price and day change unavailable
Contents
Item 1. Financial Statements
RAPHAEL PHARMACEUTICAL INC. AND ITS SUBSIDIARY
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2025
UNAUDITED
U.S. DOLLARS IN THOUSANDS
INDEX
| Page | |
| Condensed Consolidated Interim Balance Sheets (PCAOB ID No. 6816) | F-1 |
|---|---|
| Condensed Consolidated Interim Statements of Comprehensive Loss | F-2 |
| Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity | F-3 |
| Condensed Consolidated Interim Statements of Cash Flows | F-4 |
| Notes to Condensed Consolidated Interim Financial Statements | F-5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.